Competing with Magna-Labin the niche MRI segment is Lunar, which markets the Artoscanmagnet manufactured by Esaote Biomedica of Italy. Artoscan isa 0.2-tesla permanent magnet scanner optimized for extremity imaging. Lunar, of Madison, WI, will release
Competing with Magna-Labin the niche MRI segment is Lunar, which markets the Artoscanmagnet manufactured by Esaote Biomedica of Italy. Artoscan isa 0.2-tesla permanent magnet scanner optimized for extremity imaging.
Lunar, of Madison, WI, will release a new software packageat the RSNA meeting called Version 3.3 B. The package includes3-D imaging sequences and multiformat reconstruction and givesArtoscan the ability to conduct volume imaging, according to BillConn, MRI marketing manager.
Lunar is also introducing a remote diagnostics capability forthe scanner, dubbed Artoscan Remote Assistance System (ARAS).ARAS allows Lunar engineers to maintain, diagnose and providesoftware upgrades for Artoscan via modem.
Artoscan was cleared for marketing by the Food and Drug Administrationlate last year (SCAN 11/3/93). Lunar has sold 60 units worldwideand eight in the U.S., Conn said. The company expects have a U.S.installed base of 10 to 12 units by the end of the year.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.